TY - JOUR
T1 - The population effectiveness of highly active antiretroviral therapy
T2 - are good drugs good enough?
AU - Giordano, Thomas P.
AU - Suarez-Almazor, Maria E.
AU - Grimes, Richard M.
N1 - Funding Information:
The authors are supported in part by National Institutes of Health grant K23MH067505 to Thomas P. Giordano, and the facilities and resources of the Houston Center for Quality of Care and Utilization Studies, Michael E. DeBakey Veterans Affairs Medical Center.
PY - 2005/11
Y1 - 2005/11
N2 - Despite the success of highly active antiretroviral therapy (HAART) at reducing mortality from HIV infection, there is evidence that it is not reaching the all of the population that needs it, even in the developed world. To be maximally effective at the population level, all persons with HIV infection must be diagnosed; those persons with an indication for HAART must enter care, must receive HAART, and then must adhere to appointments and, finally, HAART itself. There is considerable evidence that significant portions of the population infected with HIV have not completed all of these steps of HIV care even in the developed world. Although new medications to treat HIV are certainly needed, significant improvements in viral, immunologic, and clinical outcomes could be achieved from improving timely diagnosis, access to HAART, and adherence to appointments, as well as adherence to HAART.
AB - Despite the success of highly active antiretroviral therapy (HAART) at reducing mortality from HIV infection, there is evidence that it is not reaching the all of the population that needs it, even in the developed world. To be maximally effective at the population level, all persons with HIV infection must be diagnosed; those persons with an indication for HAART must enter care, must receive HAART, and then must adhere to appointments and, finally, HAART itself. There is considerable evidence that significant portions of the population infected with HIV have not completed all of these steps of HIV care even in the developed world. Although new medications to treat HIV are certainly needed, significant improvements in viral, immunologic, and clinical outcomes could be achieved from improving timely diagnosis, access to HAART, and adherence to appointments, as well as adherence to HAART.
UR - http://www.scopus.com/inward/record.url?scp=33644844908&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33644844908&partnerID=8YFLogxK
U2 - 10.1007/s11904-005-0013-7
DO - 10.1007/s11904-005-0013-7
M3 - Review article
C2 - 16343375
AN - SCOPUS:33644844908
SN - 1548-3568
VL - 2
SP - 177
EP - 183
JO - Current HIV/AIDS reports
JF - Current HIV/AIDS reports
IS - 4
ER -